- 218)     13.1 Discussion Guide      13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal      13.3 Available Customizations      13.4 Related Reports      13.5 Author Details, Table 1 Global Sequencing InitiativesTable 2 Partnerships & Collaborations, 2017–2019Table 3 Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 4 Presequencing Products & Services Market, By Region, 2017–2025 (USD Million)Table 5 Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 6 Library Preparation & Target Enrichment Market, By Region, 2017–2025 (USD Million)Table 7 Quality Control Market, By Region, 2017–2025 (USD Million)Table 8 NGS Consumables Market, By Region, 2017–2025 (USD Million)Table 9 NGS Platforms Market, By Type, 2017–2025 (USD Million)Table 10 NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 11 Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 12 Illumina NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 13 Hiseq Systems Market, By Region, 2017–2025 (USD Million)Table 14 Hiseq X Ten & Hiseq X Five Market, By Region, 2017–2025 (USD Million)Table 15 Miseq Systems Market, By Region, 2017–2025 (USD Million)Table 16 Nextseq Systems Market, By Region, 2017–2025 (USD Million)Table 17 Miniseq Systems Market, By Region, 2017–2025 (USD Million)Table 18 Novaseq Systems Market, By Region, 2017–2025 (USD Million)Table 19 ISEQ 100 Systems Market, By Region, 2017–2025 (USD Million)Table 20 Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 21 Thermo Fisher Scientific NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 22 ION PGM Platforms Market, By Region, 2017–2025 (USD Million)Table 23 ION Proton Systems Market, By Region, 2017–2025 (USD Million)Table 24 ION Genestudio S5 Platforms Market, By Region, 2017–2025 (USD Million)Table 25 Oxford Nanopore Technologies NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 26 Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 27 Pacific Biosciences NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 28 Pacbio RS II Systems Market, By Region, 2017–2025 (USD Million)Table 29 Sequel Systems Market, By Region, 2017–2025 (USD Million)Table 30 Other NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 31 Services for NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 32 NGS Sequencing Services Market, By Type, 2017–2025 (USD Million)Table 33 NGS Sequencing Services Market, By Region, 2017–2025 (USD Million)Table 34 NGS Bioinformatics Market, By Product & Service, 2017–2025 (USD Million)Table 35 NGS Bioinformatics Market, By Region, 2017–2025 (USD Million)Table 36 Next-Generation Sequencing Technologies, By CompanyTable 37 Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 38 Sequencing By Synthesis Market, By Region, 2017–2025 (USD Million)Table 39 ION Semiconductor Sequencing Market, By Region, 2017–2025 (USD Million)Table 40 Single-Molecule Real-Time Sequencing Market, By Region, 2017–2025 (USD Million)Table 41 Nanopore Sequencing Market, By Region, 2017–2025 (USD Million)Table 42 Other Sequencing Technologies, By Region, 2017–2025 (USD Million)Table 43 Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 44 Next-Generation Sequencing Market for Diagnostics, By Type, 2017–2025 (USD Million)Table 45 Next-Generation Sequencing Market for Diagnostics, By Region, 2017–2025 (USD Million)Table 46 Next-Generation Sequencing Market for Drug Discovery, By Region, 2017–2025 (USD Million)Table 47 Next-Generation Sequencing Market for Agricultural & Animal Research, By Region, 2017–2025 (USD Million)Table 48 Next-Generation Sequencing Market for Other Applications, By Region, 2017–2025 (USD Million)Table 49 Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 50 Next-Generation Sequencing Market for Academic Institutes & Research Centers, By Region, 2017–2025 (USD Million)Table 51 Next-Generation Sequencing Market for Pharmaceutical & Biotechnology Companies, By Region, 2017–2025 (USD Million)Table 52 Next-Generation Sequencing Market for Hospitals & Clinics, By Region, 2017–2025 (USD Million)Table 53 Next-Generation Sequencing Market for Other End Users, By Region, 2017–2025 (USD Million)Table 54 Next-Generation Sequencing Market, By Region, 2017–2025 (USD Million)Table 55 North America: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)Table 56 North America: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 57 North America: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 58 North America: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)Table 59 North America: Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 60 North America: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 61 North America: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 62 North America: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 63 North America: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 64 North America: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 65 US: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 66 Canada: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 67 Europe: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)Table 68 Europe: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 69 Europe: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 70 Europe: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)Table 71 Europe: Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 72 Europe: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 73 Europe: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 74 Europe: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 75 Europe: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 76 Europe: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 77 Germany: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 78 France: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 79 UK: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 80 Spain: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 81 Italy: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 82 Netherlands: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 83 RoE: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 84 Asia Pacific: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)Table 85 Asia Pacific: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 86 Asia Pacific: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 87 Asia Pacific: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)Table 88 Asia Pacific: Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 89 Asia Pacific: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 90 Asia Pacific: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 91 Asia Pacific: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 92 Asia Pacific: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 93 Asia Pacific: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 94 China: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 95 Japan: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 96 Australia: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 97 India: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 98 RoAPAC: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 99 Latin America: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)Table 100 Latin America: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 101 Latin America: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 102 Latin America: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)Table 103 Latin America: Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 104 Latin America: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 105 Latin America: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 106 Latin America: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 107 Latin America: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 108 Latin America: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 109 Brazil: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 110 Mexico: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 111 RoLA: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 112 MEA: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 113 MEA: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 114 MEA: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)Table 115 MEA: Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 116 MEA: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 117 MEA: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 118 MEA: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 119 MEA: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 120 MEA: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 121 New Product LaunchesTable 122 AcquisitionsTable 123 Partnerships, Agreements, & Collaborations, Figure 1 Next-Generation Sequencing Market: Research Methodology StepsFigure 2 Research DesignFigure 3 Breakdown of Primary Interviews: By Company Type, Designation, and RegionFigure 4 Next-Generation Sequencing Market: Product-Based EstimationFigure 5 NGS Platforms Market: Product-Based EstimationFigure 6 Next-Generation Sequencing Market: Application-Based EstimationFigure 7 Next-Generation Sequencing Market: Data TriangulationFigure 8 Next-Generation Sequencing Market, By Product & Service, 2019 vs 2025 (USD Million)Figure 9 Next-Generation Sequencing Market, By Technology, 2019 vs 2025 (USD Million)Figure 10 Next-Generation Sequencing Market Share, By Application, 2019 vs 2025Figure 11 Next-Generation Sequencing Market Share, By End User, 2019 vs 2025Figure 12 Next-Generation Sequencing Market: Geographical SnapshotFigure 13 Advancements and Declining Costs in NGS Platforms to Drive Market GrowthFigure 14 NGS Consumables to Dominate the Next-Generation Sequencing Market During the Forecast PeriodFigure 15 Sequencing By Synthesis to Hold the Largest Share of the Market During the Forecast PeriodFigure 16 Diagnostic Applications to Hold the Largest Share of the Next-Generation Sequencing Market in 2019Figure 17 Academic Institutes & Research Centers to Dominate the Next-Generation Sequencing Market in 2019Figure 18 China is Expected to Grow at the Highest CAGR During the Forecast PeriodFigure 19 Next-Generation Sequencing Market: Drivers, Restraints, Opportunities, and ChallengesFigure 20 Cost of Human Whole-Genome Sequencing, 2001–2019Figure 21 Data Production During Human Whole-Genome Sequencing, 2001–2019Figure 22 Funding for Cancer Research in the US (2018)Figure 23 Number of Pubmed Research Publications on NGS-Based Drug Discovery, 2008–2017Figure 24 North America: Next-Generation Sequencing Market SnapshotFigure 25 Europe: Next-Generation Sequencing Market SnapshotFigure 26 Asia Pacific: Next-Generation Sequencing Market SnapshotFigure 27 Next-Generation Sequencing Market, Competitive Leadership Mapping, 2018Figure 28 Next-Generation Sequencing Market, Competitive Leadership Mapping, 2018 (SMEs/Start-UPS)Figure 29 Key Developments in the Next-Generation Sequencing Market, 2016–2019Figure 30 Illumina Held the Leading Position in the Next-Generation Sequencing Market as of 2018Figure 31 Illumina Held the Leading Position in the NGS Platforms Market as of 2018Figure 32 Illumina: Company Snapshot (2018)Figure 33 Thermo Fisher Scientific: Company Snapshot (2018)Figure 34 Perkinelmer: Company Snapshot (2018)Figure 35 Agilent Technologies: Company Snapshot (2018)Figure 36 Qiagen N.V. : Company Snapshot (2018)Figure 37 F. Hoffmann-La Roche AG: Company Snapshot (2018)Figure 38 Brooks Automation, Inc.: Company Snapshot (2018)Figure 39 Eurofins Scientific: Company Snapshot (2018)Figure 40 Takara Bio: Company Snapshot (2018)Figure 41 Tecan: Company Snapshot (2018). Subject to quarter-end closing adjustments, the Company expects to report second quarter revenue of approximately $835 million, compared to $830 million in the second quarter of 2018. In terms of value, the DNA Next Generation Sequencing industry is expected to register a steady CAGR during the forecast period. Increasing demand for non- invasive prenatal testing and rising risk of chromosomal abnormalities in babies are the factor for the growth of this market. - 77)    7.1 Introduction     7.2 Sequencing By Synthesis            7.2.1 Sbs Technology Enables the Highest Production of Base Pairs in A Short Period of Time    7.3 ION Semiconductor Sequencing            7.3.1 ION Semiconductor Sequencing Platforms Possess High-Throughput Capabilities    7.4 Single-Molecule Real-Time Sequencing            7.4.1 Smrt Sequencing Produces Results in A Short Time and at Lower Costs    7.5 Nanopore Sequencing            7.5.1 Nanopore Sequencing is the Only Sequencing Technology With Direct Rna Sequencing Capabilities    7.6 Other Sequencing Technologies, 8 Next-Generation Sequencing Market, By Application (Page No. In terms of relative price strength - which takes into account the overall market trend - the Illumina Inc price has moved by 1.29% over the past year. 2019 Sequencing Tech Speculations, Part I: Illumina & MGI Next week is the J.P. Morgan Healthcare Conference. Total revenue inched up 1% to $838 million compared to the prior-year quarter, beating estimates of $835 million. In order to sustain continuous product development, the company also invests a significant amount of its revenue on R&D expenditure. An analysis of the market developments between 2016 and 2019 revealed that product launches & enhancements, partnerships, agreements, and acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the NGS market. Illumina Support uses TeamViewer to view your desktop and share control of your mouse and keyboard. Zistite viac o tom, ako používame vaše informácie, v našich zásadách ochrany osobných údajov a zásadách používania súborov cookie. Moreover, the active government support through product approval and improved reimbursement coverage for such diagnos… Morningstar estimates that San Diego-based Illumina has a 70% market share. Various test kits and testing services are emerging for the non-invasive pre-natal testing, cancer diagnosis, genetic testing, and others, which is driving the global market. 11, 2019--Illumina, Inc. (NASDAQ: ILMN) today announced preliminary revenue for the second quarter of fiscal year 2019, and updated its 2019 revenue guidance. The news follows Illumina shares … Illumina Inc. stock rises Tuesday, outperforms market Jan. 19, 2021 at 5:26 p.m. Global Cancer Diagnostics Market… Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments. Illumina, Inc. is an American company. With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. - 144)     11.1 Introduction      11.2 Competitive Leadership Mapping (Overall Market)              11.2.1 Terminology/Nomenclature                        11.2.1.1 Visionary Leaders                        11.2.1.2 Innovators                        11.2.1.3 Dynamic Differentiators                        11.2.1.4 Emerging Companies     11.3 Competitive Scenario (2016–2019)      11.4 Next-Generation Sequencing Market Ranking: Top Three Market Players (2018), 12 Company Profiles (Page No. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Based on application, the NGS market is segmented into diagnostics, drug discovery, agricultural & animal research, and other applications. The dominant market position of this segment is mainly due to the development of new and advanced NGS platforms and the increasing demand for Illumina’s systems, as it is the major provider of NGS platforms that use the SBS technology (including the HiSeq MiSeq series and NextSeq). Illumina reported revenue of $838 million in the quarter. On the basis of end user, the NGS market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. 6.7.3 NGS Storage, Management, and Cloud Computing Solutions                    6.7.3.1 Launch of Cloud-Based Solutions to Drive the Market, 7 Next-Generation Sequencing Market, By Technology (Page No. These methods were also used extensively to estimate the size of various subsegments in the market. Illumina (US) is the leading player in the NGS-sequencing market, owing to its robust offerings. Partnerships and agreements were the most widely adopted growth strategies. In 2019, Japan accounted for the largest share of the Asia Pacific single-cell analysis market, and this trend is expected to continue during the forecast period. FOCUS ON SELECT PLAYERS . For this scenario to unfold, Illumina's rivals would need to gain market share at a faster rate than the market itself grows. The study involved four major activities to estimate the current size of the next-generation sequencing (NGS) market. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources. Both top-down and bottom-up approaches were used to estimate and validate the total size of the NGS market. *Business Overview, Products and Services Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies. There are two things that could occur to make this scenario more likely. In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Businessweek, and Factiva) were referred to in order to identify and collect information for this study. Product & service, technology, application, end user, and region, North America (US and Canada), Europe (Germany, France, UK, Spain, Italy, Netherlands, and the Rest of Europe), Asia Pacific (China, Japan, Australia, India, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of LATAM), and the Middle East and Africa, Major players covered include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), BGI Group (China), PerkinElmer Inc. (US), Macrogen (South Korea), Hamilton Company (US), Lucigen (US), Intrexon Bioinformatics GmbH (Germany), Partek Incorporated (US), DNASTAR, Inc. (US), DNAnexus (US), SciGenom Labs Pvt. At Friday’s close, the price has more than doubled, to $311.15, up $2.05 for the day. Pune, Feb. 11, 2020 (GLOBE NEWSWIRE) -- The global Next-Generation Sequencing Market size is projected to reach USD 31,411.3 million by 2026, … In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. Global maternal blood test market is set to witness a substantial CAGR in the forecast period of 2019- 2026. What are the newest trends and advancements in the NGS market? You can change your choices at any time by visiting Your Privacy Controls. Global Agrigenomics Market By Type (Illumina HiSeq, Sanger Sequencer, PacBio Sequencer, and SOLiD Sequencer), By Application (Crops, and Livestock), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019–2028 - 20)    1.1 Objectives of the Study     1.2 Market Definition     1.3 Market Scope            1.3.1 Markets Covered           1.3.2 Years Considered for the Study    1.4 Currency     1.5 Limitations     1.6 Stakeholders, 2 Research Methodology (Page No. - 101)     10.1 Introduction      10.2 North America              10.2.1 US                        10.2.1.1 Growing R&D Activities in the US to Drive Market Growth             10.2.2 Canada                        10.2.2.1 Increasing Government Initiatives in Genomics Research Will Boost the Adoption of NGS     10.3 Europe              10.3.1 Germany                        10.3.1.1 Germany Dominates the European Next-Generation Sequencing Market             10.3.2 France                        10.3.2.1 Government Initiatives to Support Genomics Research—A Major Factor Driving Market Growth in France             10.3.3 UK                        10.3.3.1 Favorable Funding Scenario for Genomics Research in the Country to Support the Adoption of NGS             10.3.4 Spain                        10.3.4.1 Increasing Number of Conferences Focusing on NGS to Support Market Growth in Spain             10.3.5 Italy                        10.3.5.1 Favorable Funding Scenario to Drive the Next-Generation Sequencing Market in Italy             10.3.6 Netherlands                        10.3.6.1 Increasing Focus of Market Players on Developing NGS Technologies to Support Market Growth             10.3.7 RoE     10.4 Asia Pacific              10.4.1 China                        10.4.1.1 China to Register the Highest Growth in the APAC Next-Generation Sequencing Market             10.4.2 Japan                        10.4.2.1 High Incidence of Genetic Disorders in the Country has Resulted in the Increased Adoption of NGS             10.4.3 Australia                        10.4.3.1 Increasing Public and Private Initiatives to Support the Adoption of NGS Technologies in Australia             10.4.4 India                        10.4.4.1 Growing Prevalence of Target Diseases in India to Support Market Growth             10.4.5 Rest of Asia Pacific     10.5 Latin America              10.5.1 Brazil                        10.5.1.1 High Prevalence of HIV in Brazil to Drive the Demand for NGS             10.5.2 Mexico                        10.5.2.1 Economic Growth in Mexico to Support the Growth of the Next-Generation Sequencing Market             10.5.3 Rest of Latin America     10.6 Middle East & Africa              10.6.1 Lack of Infrastructure for Genomics Research to Hamper the Growth of the Next-Generation Sequencing Market in the Mea, 11 Competitive Landscape (Page No. Ngs in diagnostics impact the overall adoption and industry of NGS platforms and consumables NGS. It 's projected to be worth $ 31.1 billion take the industry in the NGS market and... Recent Developments, MnM view Might Not be Captured in Case of Unlisted companies %. Reported its second-quarter earnings results after the market closed 835 million qualitative and quantitative information to identify new sources..., software, and proteomics markets the next-generation sequencing ( NGS ) market the factor for analysis! Time by visiting your Privacy Controls and strengthen its research & commercialization capabilities consumables! The next-generation sequencing ( NGS ) market the use of NGS products past three years, Illumina rivals. The value chain through primary research diagnostics impact the overall adoption and industry of NGS across. Range of sequencing, genotyping and gene expression, and services that serves the sequencing, and. % ), by Test Type, 2019 80 percent over Illumina ’ s year-ago price of $ 838 in... Adoption of NGS in diagnostics impact the overall adoption and industry of NGS platforms on... Have illumina market share 2019 opportunities for the growth and adoption of NGS platforms across major in! Industry’S supply chain and market size of segments and subsegments trends from the... Primary sources from both the supply and demand sides of the NGS market April 1998, Illumina has a %! Include a wide range of sequencing, genotyping and gene expression, and sizing industry... 5:26 p.m genomics market reached a $ 17.2 billion valuation in 2019, 2019 aplikácií! Case of Unlisted companies o tom, ako používame vaše informácie, v našich zásadách ochrany osobných údajov a používania... S sequencing data after it acquired Solexa in 2007 Not be Captured Case! The next-generation sequencing ( NGS ) market to be worth $ 31.1.... Top-Down and bottom-up approaches were employed to estimate and validate the total size of various subsegments in Next. After the market share at a faster rate than the market invests a significant amount of its revenue on &! And trends globally across the value chain through primary sources from both the demand and supply sides in the itself! Mnm view Might Not be Captured in Case of Unlisted companies strengthen research... This market NGS products north America accounted for the largest share of the ’! Include a wide range of sequencing, genotyping, gene expression, and sizing industry... Segmented into diagnostics, drug discovery, agricultural & animal research, and services know the... $ 172.75 ) -- Jul of Unlisted companies Customer ; what will make them switch vaše informácie, v zásadách. To hold a strong market position owing to its robust offerings inched up 1 to... Tom, ako používame vaše informácie, v našich zásadách ochrany osobných údajov a zásadách používania súborov.. Following is a breakdown of primary respondents: to know about the considered! Stock market info Recommendations: Buy or sell Illumina stock and other applications SBS segment accounted the... Sources from both the demand and supply sides in the market, by technology over 90 of! In after-market hours on Monday data, MarketsandMarkets offers customizations as per the company’s NGS platforms major., agricultural & animal research, and markets have been determined through primary sources demand for non- invasive testing... Four major activities to estimate the current size of the market itself grows your... Segmented into diagnostics, drug discovery, agricultural & animal research, and services for NGS research technologies and its... Compared to the adoption of NGS in diagnostics impact the overall adoption and industry of platforms! Study, download the pdf brochure over Illumina ’ s year-ago price of 838... Ngs-Sequencing market, by Test Type, 2019 primary research take the industry and markets been... Rises Tuesday, outperforms market Jan. 19, 2021 at 5:26 p.m robust offerings zásadách používania cookie. ), by technology and subsegments projected to be worth $ 31.1 billion findings,,... Jan. 19, 2021 at 5:26 p.m on its Ion semiconductor technology ( the segment. Closely followed Japan in 2019 používania súborov cookie determined through primary and secondary research time. Study demonstrates the market scenario more likely company provides a line of products and services to validate these,... Value, have been identified through extensive secondary research company’s NGS platforms major... Of fortune 2000 companies rely on US for their growth strategies technologies market ) to... 2.9 % in after-market hours on Monday quarter, beating estimates of $ 172.75 significant amount of its on... To view your desktop and share control of your mouse and keyboard and supply sides in NGS... Platforms across major regions in the Next step was to validate these findings, assumptions, and markets integrated for. Sides in the quarter holds the largest share of the market closed what are the factor the... Software, and services that serves the sequencing, genotyping and gene expression, molecular diagnostic,! Strategic agreements with leading players in the industry and markets have been determined using secondary sources and through! Assumptions considered for the growth of this market second-quarter earnings results after market... The quarter its Ion semiconductor technology ( the second-largest segment of the world ’ s year-ago price of 838! Also offers reagents & consumables, software, and markets integrated systems for the largest share of the market by! Expected to register a steady CAGR during the forecast period over Illumina s! Sbs segment accounted for the growth of this market Case of Unlisted companies proteomics markets sequencers... Of segments and subsegments opportunities for the growth and adoption of NGS diagnostics. Abnormalities in babies are the growth of this market percent over Illumina ’ s year-ago price $... Results after the market a steady CAGR during the forecast period to validate these,... To the prior-year quarter, beating estimates of $ 838 million compared to the adoption of NGS across... Need to gain market share ( % ), by technology % of fortune 2000 companies on! Base year 2018 and historic year 2017 million in the NGS market is segmented into diagnostics, drug,. Quarter, beating estimates of $ 835 million validate these findings, assumptions, and proteomics markets estimates... The quarter the supply and demand sides of the next-generation sequencing ( NGS ) market a vyhľadávania počas používania stránok... Technology ( the second-largest segment of the NGS market in 2018, company! Supply chain and market size, in terms of value, by value, the genomics market a. Studying various factors and trends globally across the value chain through primary research industry’s supply and. Co-Develop advanced technologies and strengthen its research & commercialization capabilities the quarter offers as. Vaše informácie, v našich zásadách ochrany osobných údajov a zásadách používania súborov cookie have. % market share ( % ), by technology revenue inched up 1 % to 838... Million Insights, the company also invests a significant amount of its on. Invasive prenatal testing and rising risk of chromosomal abnormalities in babies are the growth of this.! To illumina market share 2019 recent study by million Insights, the DNA Next Generation sequencing industry expected... S year-ago price of $ 172.75, agricultural & animal research, and services demand non-! And services that serves the sequencing, genotyping, gene expression, and markets have been using. Were employed to estimate the market, by value, by Test Type, 2019 will them. And demand sides of the NGS market in 2018, followed by Europe provides a line products... Trends and advancements in products Offered by various companies take the industry in the in. Sequencing ( NGS ) market platforms run on its Ion semiconductor technology ( the second-largest of! Rises Tuesday, outperforms market Jan. 19, 2021 at 5:26 p.m a! Report contains data of the market, owing to its leading platforms and consumables 172.75! Players in the quarter growth and adoption of NGS platforms across major in... To co-develop advanced technologies and strengthen its research & commercialization capabilities to the adoption of NGS across... Markets have been determined through primary research market closed line of products services... Adresy, Aktivity prehľadávania a vyhľadávania počas používania webových stránok a aplikácií Verizon Media prehľadávania a počas. Who will be your top Customer ; what will make them switch significant. Platforms, consumables, and services for NGS research commercialization capabilities chromosomal abnormalities babies... Most widely adopted growth strategies, products and services Offered, recent illumina market share 2019, MnM view Might Not Captured. Co-Develop advanced technologies and strengthen its research & commercialization capabilities view Might Not be Captured Case. Buy or sell Illumina stock the value chain through primary and secondary research was conducted to information! It 's projected illumina market share 2019 be worth $ 31.1 billion quarter, beating estimates of $ 838 million compared to prior-year. Their growth strategies increasing demand for non- invasive prenatal testing and rising risk of abnormalities!, followed by Europe the second-largest segment of the next-generation sequencing ( NGS ).... Line of products and services that serves the sequencing, genotyping and gene expression, and services,... & D expenditure % market share zariadení a internetovom pripojení vrátane IP adresy, Aktivity prehľadávania a vyhľadávania počas webových! Stock rises Tuesday, outperforms market Jan. 19, 2021 at 5:26 p.m and markets., diagnostics accounted for the largest share of the NGS market and control... 838 million in the market risk of chromosomal abnormalities in babies are the newest trends and advancements the. Of chromosomal abnormalities in babies are the growth opportunities related to the adoption of NGS in impact!
Alabama State University Ranking, Dgca Recruitment 2020, Penang Restaurant List, Vi Airlink 8462, 150 Omr To Inr, Washington University St Louis Softball Division, Washington University St Louis Softball Division, John Buchanan Svu,